Levy Yuval, Frenkel Nir Yael, Ironi Avinoah, Englard Hindy, Regev-Yochay Gili, Rahav Galia, Afek Arnon, Grossman Ehud
Department of Medical Management, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Isr Med Assoc J. 2020 Aug;22(8):470-475.
Sheba Medical Center, Tel Hashomer, is a tertiary hospital located in the center of Israel. It is the largest hospital in Israel and was the first to face coronavirus disease-2019 (COVID-19) patients in the country at the beginning of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic.
To describe our experience with the COVID-19 pandemic, focusing on our triage method in the emergency department (ED). Our goal was to keep the main hospitalization buildings clean of infection by separating COVID-19 positive patients from COVID-19 negative patients.
We divided our ED into two separate sections: a regular non-COVID-19 ED and an advanced biological ED. We created clear protocols of triage for suspected and confirmed COVID-19 patients. We reviewed the data of patients admitted to our ED during the month of March and analyzed the results of our triage method in separating COVID-19 positive from negative patients.
During the month of March 2020, 7957 patients were referred to our ED. Among them 2004 were referred to the biological ED and 5953 were referred to the regular ED. Of the 2004 patients referred to the biological ED, 1641 (81.8%) were sampled for SARS-CoV-2 polymerase chain reaction of whom 143 (8.7%) were positive. Only two COVID-19 positive patients unintentionally entered the main clean hospital, making our triage almost full proof.
Our triage method was successful in separating COVID-19 positive from negative patients and maintained the regular hospital clean of COVID-19 allowing treatment continuation of regular non-COVID-19 patients.
位于特拉维夫哈希默的谢巴医疗中心是一家位于以色列中部的三级医院。它是以色列最大的医院,在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行初期是该国首个接诊2019冠状病毒病(COVID-19)患者的医院。
描述我们在COVID-19大流行中的经验,重点是我们在急诊科(ED)的分诊方法。我们的目标是通过将COVID-19阳性患者与COVID-19阴性患者分开,使主要住院大楼保持无感染状态。
我们将急诊科分为两个独立区域:普通非COVID-19急诊科和高级生物急诊科。我们为疑似和确诊的COVID-19患者制定了明确的分诊方案。我们回顾了3月份入住我们急诊科的患者数据,并分析了我们在区分COVID-19阳性和阴性患者方面的分诊方法结果。
2020年3月期间,7957名患者被转诊至我们的急诊科。其中2004名被转诊至生物急诊科,5953名被转诊至普通急诊科。在被转诊至生物急诊科的2004名患者中,1641名(81.8%)接受了SARS-CoV-2聚合酶链反应检测,其中143名(8.7%)呈阳性。只有两名COVID-19阳性患者意外进入了医院的主要清洁区域,这使得我们的分诊几乎万无一失。
我们的分诊方法成功地将COVID-19阳性患者与阴性患者分开,并使普通医院保持无COVID-19状态,从而使普通非COVID-19患者能够继续接受治疗。